Controlling CAR-T cell activity and specificity with synthetic SparX adapters
Open Access
- 23 April 2024
- journal article
- research article
- Published by Elsevier in Molecular Therapy
- Vol. 32 (6) , 1835-1848
Abstract
No abstract availableKeywords
This publication has 38 references indexed in Scilit:
- Adapter CAR T cells to counteract T-cell exhaustion and enable flexible targeting in AMLLeukemia, 2023
- CAR-T cell therapy: current limitations and potential strategiesBlood Cancer Journal, 2021
- A modular and controllable T cell therapy platform for acute myeloid leukemiaLeukemia, 2021
- Chimeric Antigen Receptors Incorporating D Domains Targeting CD123 Direct Potent Mono- and Bi-specific Antitumor Activity of T CellsMolecular Therapy, 2019
- CAR T Cells with Enhanced Sensitivity to B Cell Maturation Antigen for the Targeting of B Cell Non-Hodgkin’s Lymphoma and Multiple MyelomaMolecular Therapy, 2018
- Switching CAR T cells on and off: a novel modular platform for retargeting of T cells to AML blastsBlood Cancer Journal, 2016
- 4-1BB costimulation ameliorates T cell exhaustion induced by tonic signaling of chimeric antigen receptorsNature Medicine, 2015
- Alpha-fetoprotein: a renaissanceTumor Biology, 2013
- Hydrophobic Core Malleability of a De Novo Designed Three-helix Bundle ProteinJournal of Molecular Biology, 2001
- Isolation and Structural and Functional Characterization of Two Stable Peptic Fragments of Human α-FetoproteinBiochemistry, 1999